Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: Patency and clinical outcome at 1 year
Authors:
- Wiek H. van GilstWGWiek H. van Gilst
- Hans L. HillegeHHHans L. Hillege
- Kong I. LieKLKong I. Lie
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prevention of one-year vein-graft occlusion after aortocoronary- bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulantsThe Lancet, 1993
- A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic StrokeNew England Journal of Medicine, 1991
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Internal mammary artery: methods of use and their effect on survival after coronary bypass surgeryEuropean Journal of Cardio-Thoracic Surgery, 1990
- Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.Circulation, 1989
- The statistical analysis of graft patency data in a clinical trial of antiplatelet agents following coronary artery bypass graftingControlled Clinical Trials, 1988
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986
- IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)The Lancet, 1984
- Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass OperationsNew England Journal of Medicine, 1984
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983